Decision-making and Risk-taking in Bulimia (FaciB)

September 9, 2021 updated by: Hôpital le Vinatier

Identification of Decision Making Processes in Food, Risky and Steal Situations in Bulimia Nervosa

This trial is a set of four independent experiments involving for each of them functional and structural MRI data acquisition. They aim at investigating decision making mechanisms in bulimia nervosa when participants have to make food or monetary choices under specific conditions that mimic binge eating episodes or kleptomania which are two major symptoms of bulimia nervosa. All experiments are cross sectional studies. Each experiment is subdivided into two parts: a first part without any MRI data acquisition and during which all the tasks are performed. This part aims at making sure that a behavioral effect is observed before starting MRI data acquisition. The second part aims at investigating the neural correlates observed in the first part and additionally, at reproducing the behavioral effects observed in the first part. Therefore the first part may be regarded as an independent study as compared to the second part.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

Each part of each experiment is built of a main task, a set of secondary tasks and questionnaires. Only the main task changes from one experiment to another. Within each experiment, the only difference between the two parts is that the main task is performed while participants are being scanned in an MRI scanner. Details of the tasks are provided below. Each part of each experiment is performed over one visit only and is a cross sectional study. The visit is dedicated to the tasks. Questionnaires may be filled during the visit or at participant's home within the week following the visit for questionnaires which are not assessing participant's state. Questionnaires assessing participant's state are filled during the visit at appropriate time. The total number of participants mentioned below is the sum of the planned number of participants within each group, i.e. patients and healthy participants, within each part of each experiment.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhone Alpes
      • Lyon, Rhone Alpes, France, 69678
        • Hopital Vinatier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 31 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • men and women aged 18 to 35 years with bulimia nervosa according to DSM 5 criteria for the patient's group
  • For the control group, men and women with the same age range being concerned by food intake and their body shape but without any history of eating disorder.
  • All participants must have signed an informed consent form and be affiliated to the French public health insurance.
  • for MRI scans, all participants must be right handed.

Exclusion Criteria:

  • antisocial personality disorder,
  • borderline personality disorder
  • addiction to alcohol or psychoactive agent, ADHD, any psychotic disorder,
  • obesity of class 1 or 2
  • istory of psychiatric disorder for the control group
  • history of neurological disorder for both groups
  • intermittent explosive disorder
  • any counter indication to MRI scans for the parts of experiments which take place in the MRI scanner.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: bulimia nervosa group
Patients with Bulimia Nervosa according to DSM 5 criteria aged between 18 and 35 years and specifically for participants attending MRI scans in the experiments: no counter indication to MRI scans and right handed.

Each of the 4 experiments is built of a main task. The first task involves a first phase of subjective valuation of food items.

The second phase requires from the participant to make a choice between two out of three food items selected by the computer.

Other: Control group
healthy participants without any history of eating disorder aged between 18 and 35 years and specifically for participants attending MRI scans in the experiments: no counter indication to MRI scans and right

Each of the 4 experiments is built of a main task. The first task involves a first phase of subjective valuation of food items.

The second phase requires from the participant to make a choice between two out of three food items selected by the computer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxygen variation in the brain
Time Frame: 10 days

Brain activity related to task performance collected in the MRI scanner.Blood Oxygen Level Dependent response synchronized with any event of interest during the task. Events of interests are:

  • Onset time of any visual stimulus
  • Onset time of any response of the participant.
10 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Task related parameters
Time Frame: 10 days

reaction times computed as the duration in ms between the onset time of the stimulus and the onset time of the participant's answer. Several tasks may be involved in each experiment including in the MRI scan.

These rules apply to all tasks.

10 days
Skin conductance response related to events in the task performed while the signal is being collected
Time Frame: 10 days

Skin conductance response in microSiemens synchronized with any event of interest during the task. Events of interests are:

  • Onset time of any visual stimulus
  • Onset time of any response of the participant
10 days
cardiac frequency in beats per minute related to events in the task performed while the signal is being collected
Time Frame: 10 days
cardiac frequency is computed from the pulse plethysmogram sensor signal while the participant is performing the task. Task during which this signal is collected may be one of the tasks performed in the scanner as well as tasks performed outside the scanner.
10 days
parameters of eye movements extracted from the eye tracking signal is being collected
Time Frame: 10 days
The parameters computed are X and Y position of the eye by amplitude of variation of pupil size over a time window synchronized with events in the task
10 days
Eating Disorders Examination (EDE-Q)
Time Frame: 10 days
The EDE is a semi-structured interview conducted by a trained clinician to assess the psychopathology associated with the diagnosis of an eating disorder. The EDE is rated through the use of four subscales (restraint, eating concern, weight concern, shape concern) and global score.
10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 28, 2020

Primary Completion (Actual)

June 15, 2021

Study Completion (Actual)

June 15, 2021

Study Registration Dates

First Submitted

July 25, 2019

First Submitted That Met QC Criteria

July 30, 2019

First Posted (Actual)

August 1, 2019

Study Record Updates

Last Update Posted (Actual)

September 16, 2021

Last Update Submitted That Met QC Criteria

September 9, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bulimia Nervosa

Clinical Trials on tasks and questionnaires

Subscribe